Sfoglia per Rivista VACCINE
The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines
2015-01-01 Lopalco, PIETRO LUIGI; Destefano, F.
Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)
2019-01-01 Kissling, ; Pozo, ; Buda, ; Vilcu, ; A., -M.; Rizzo, C; Gherasim, ; Horváth, ; J., K.; Brytting, ; Domegan, ; Meijer, ; Paradowska-Stankiewicz, ; Machado, ; Vučina, ; V., V.; Lazar, ; Johansen, ; Dürrwald, ; Van Der, Werf; Bella, ; Larrauri, ; Ferenczi, ; Zakikhany, ; O'Donnell, ; Dijkstra, ; Bogusz, ; Guiomar, ; Filipović, ; S., K.; Pitigoi, ; Penttinen, ; Valenciano, ; Petrović, ; Makarić, ; Z., L.; Novosel, ; I., P.; Zajec, ; Kaić, ; Behillil, ; Enouf, ; Lina, ; Virpath, ; Valette, ; Preuß, ; Reuß, ; Biere, ; Smallfield, ; Schweiger, ; Wedde, ; Oroszi, ; Vizler, ; Hercegh, ; Szalai, ; Coughlan, ; Dunford, ; Moran, ; Connell, ; De, Gascun; Tuite, ; Collins, ; Joyce, ; Levis, ; Castrucci, ; M., R.; Puzelli, ; Alfonsi, ; Appelgreen, ; De, Lange; Van Den, Brink; Overduin, ; Teirlinck, ; Reukers, ; Van Der, Hoek; Donker, ; Hooiveld, ; Gomez, ; Kislaya, ; Nunes, ; Rodrigues, ; A., P.; Conde, ; Costa, ; Cristóvão, ; Pechirra, ; Lupulescu, ; Alina, ; Elena, ; M., M.; Cherciu, ; C., M.; Stoian, ; Mazagatos, ; Casas, ; Comas, ; L., G.; Marisquerena, ; M. E., I.; Galán, ; J., C.; Carril, ; F., G.; Martínez, ; R., S.; Cilla, ; Castilla, ; Cenoz, ; M., G.; Navascués, ; Rubio, ; C., Q.; Ochoa, ; E., M.; Blasco, ; Duran, ; J., G.; Vanrell, ; J., M.; Reina, ; Castrillejo, ; Wiman, ; Carnahan, ; Moren, ; I-MOVE/I-MOVE+ study team, 1
European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era.
2014-01-01 Navarro Torné, A; Dias, Jg; Quinten, C; Hruba, F; Busana, Mc; Lopalco, PIETRO LUIGI; Gauci, Aj; Pastore Celentano, L; ECDC country experts for pneumococcal, Disease
Impact of measles national vaccination coverage on burden of measles across 29 Member States of the European Union and European Economic Area, 2006-2011.
2014-01-01 Colzani, E; Mcdonald, Sa; Carrillo Santisteve, P; Busana, Mc; Lopalco, PIETRO LUIGI; Cassini, A.
Influenza vaccine uptake in the elderly population: Individual and general practitioner's determinants in Central Italy, Lazio region, 2016–2017 season
2019-01-01 Fabiani, ; Volpe, ; Faraone, ; Bella, ; Rizzo, C; Marchetti, ; Pezzotti, ; Chini,
Parental vaccine hesitancy in Italy - Results from a national survey
2018-01-01 Giambi, C; Fabiani, M; D'Ancona, F; Ferrara, L; Fiacchini, D; Gallo, T; Martinelli, D; Pascucci, Mg; Prato, R; Filia, A; Bella, A; Del Manso, M; Rizzo, C; Rota, Mc.
The use of web analytics combined with other data streams for tailoring online vaccine safety information at global level: The Vaccine Safety Net's web analytics project
2020-01-01 Gesualdo, ; Marino, ; Mantero, ; Spadoni, ; Sambucini, ; Quaglia, ; Rizzo, C; Sahinovic, ; Zuber, ; P. L., F.; Tozzi, ; A., E.; the VSN-WAP study, Group
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries
2019-01-01 Madeddu, G.; Vroling, H.; Oordt-Speets, A.; Babudieri, S.; O'Moore, E.; Noordegraaf, M. V.; Monarca, R.; Lopalco, P. L.; Hedrich, D.; Tavoschi, L.
Vaccine effectiveness against laboratory-confirmed influenza in Europe – Results from the DRIVE network during season 2018/19
2020-01-01 Stuurman, A. L.; Bollaerts, K.; Alexandridou, M.; Biccler, ; Díez Domingo, J.; Nohynek, H.; Rizzo, C; Turunen, T.; Riera-Montes, M.; DRIVE Public, Partners
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines | 1-gen-2015 | Lopalco, PIETRO LUIGI; Destefano, F. | |
| Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18) | 1-gen-2019 | Kissling, ; Pozo, ; Buda, ; Vilcu, ; A., -M.; Rizzo, C; Gherasim, ; Horváth, ; J., K.; Brytting, ; Domegan, ; Meijer, ; Paradowska-Stankiewicz, ; Machado, ; Vučina, ; V., V.; Lazar, ; Johansen, ; Dürrwald, ; Van Der, Werf; Bella, ; Larrauri, ; Ferenczi, ; Zakikhany, ; O'Donnell, ; Dijkstra, ; Bogusz, ; Guiomar, ; Filipović, ; S., K.; Pitigoi, ; Penttinen, ; Valenciano, ; Petrović, ; Makarić, ; Z., L.; Novosel, ; I., P.; Zajec, ; Kaić, ; Behillil, ; Enouf, ; Lina, ; Virpath, ; Valette, ; Preuß, ; Reuß, ; Biere, ; Smallfield, ; Schweiger, ; Wedde, ; Oroszi, ; Vizler, ; Hercegh, ; Szalai, ; Coughlan, ; Dunford, ; Moran, ; Connell, ; De, Gascun; Tuite, ; Collins, ; Joyce, ; Levis, ; Castrucci, ; M., R.; Puzelli, ; Alfonsi, ; Appelgreen, ; De, Lange; Van Den, Brink; Overduin, ; Teirlinck, ; Reukers, ; Van Der, Hoek; Donker, ; Hooiveld, ; Gomez, ; Kislaya, ; Nunes, ; Rodrigues, ; A., P.; Conde, ; Costa, ; Cristóvão, ; Pechirra, ; Lupulescu, ; Alina, ; Elena, ; M., M.; Cherciu, ; C., M.; Stoian, ; Mazagatos, ; Casas, ; Comas, ; L., G.; Marisquerena, ; M. E., I.; Galán, ; J., C.; Carril, ; F., G.; Martínez, ; R., S.; Cilla, ; Castilla, ; Cenoz, ; M., G.; Navascués, ; Rubio, ; C., Q.; Ochoa, ; E., M.; Blasco, ; Duran, ; J., G.; Vanrell, ; J., M.; Reina, ; Castrillejo, ; Wiman, ; Carnahan, ; Moren, ; I-MOVE/I-MOVE+ study team, 1 | |
| European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era. | 1-gen-2014 | Navarro Torné, A; Dias, Jg; Quinten, C; Hruba, F; Busana, Mc; Lopalco, PIETRO LUIGI; Gauci, Aj; Pastore Celentano, L; ECDC country experts for pneumococcal, Disease | |
| Impact of measles national vaccination coverage on burden of measles across 29 Member States of the European Union and European Economic Area, 2006-2011. | 1-gen-2014 | Colzani, E; Mcdonald, Sa; Carrillo Santisteve, P; Busana, Mc; Lopalco, PIETRO LUIGI; Cassini, A. | |
| Influenza vaccine uptake in the elderly population: Individual and general practitioner's determinants in Central Italy, Lazio region, 2016–2017 season | 1-gen-2019 | Fabiani, ; Volpe, ; Faraone, ; Bella, ; Rizzo, C; Marchetti, ; Pezzotti, ; Chini, | |
| Parental vaccine hesitancy in Italy - Results from a national survey | 1-gen-2018 | Giambi, C; Fabiani, M; D'Ancona, F; Ferrara, L; Fiacchini, D; Gallo, T; Martinelli, D; Pascucci, Mg; Prato, R; Filia, A; Bella, A; Del Manso, M; Rizzo, C; Rota, Mc. | |
| The use of web analytics combined with other data streams for tailoring online vaccine safety information at global level: The Vaccine Safety Net's web analytics project | 1-gen-2020 | Gesualdo, ; Marino, ; Mantero, ; Spadoni, ; Sambucini, ; Quaglia, ; Rizzo, C; Sahinovic, ; Zuber, ; P. L., F.; Tozzi, ; A., E.; the VSN-WAP study, Group | |
| Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries | 1-gen-2019 | Madeddu, G.; Vroling, H.; Oordt-Speets, A.; Babudieri, S.; O'Moore, E.; Noordegraaf, M. V.; Monarca, R.; Lopalco, P. L.; Hedrich, D.; Tavoschi, L. | |
| Vaccine effectiveness against laboratory-confirmed influenza in Europe – Results from the DRIVE network during season 2018/19 | 1-gen-2020 | Stuurman, A. L.; Bollaerts, K.; Alexandridou, M.; Biccler, ; Díez Domingo, J.; Nohynek, H.; Rizzo, C; Turunen, T.; Riera-Montes, M.; DRIVE Public, Partners |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile